Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine.
about
Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.Palpable purpura complicated by streptococcal toxic shock syndrome resulting in limb necrosis and amputation: a case of levamisole and cocaine coingestion.Characteristic purpura of the ears, vasculitis, and neutropenia--a potential public health epidemic associated with levamisole-adulterated cocaine.Levamisole in cocaine: unexpected news from an old acquaintance.Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.Cutaneous vasculopathy associated with levamisole-adulterated cocaineReversible retiform purpura: a sign of cocaine useAntineutrophil cytoplasmic antibodies, autoimmune neutropenia, and vasculitisPathologic manifestations of levamisole-adulterated cocaine exposureGenetic determinants of cocaine-associated agranulocytosis.Contaminated cocaine and antineutrophil cytoplasmic antibody-associated diseaseLevamisole-induced occlusive necrotising vasculitis in cocaine abusers: an unusual cause of skin necrosis and neutropenia.Cutaneous Necrotizing Vasculitis and Leukopenia in a Cocaine User: Is Levamisole the Culprit?Necrosis of ears after use of cocaine probably adulterated with levamisole.Levamisole exposure and hematologic indices in cocaine users.Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature.Classical and novel psychoactive substances: rethinking drug misuse from an evolutionary psychiatric perspective.Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis.Levamisole-contaminated cocaine: an emergent cause of vasculitis and skin necrosis.Cocaine-Levamisole-Induced Vasculitis/Vasculopathy Syndrome.Wide-range screening of psychoactive substances by FIA-HRMS: identification strategies.Determination of phenyltetrahydroimidazothiazole enantiomers (Levamisole/Dexamisole) in illicit cocaine seizures and in the urine of cocaine abusers via chiral capillary gas chromatography-flame-ionization detection: clinical and forensic perspectivNecrotizing peripheral vasculitis/vasculopathy following the use of cocaine laced with levamisole.Levamisole-adulterated in cocaine causing agranulocytosis, vasculopathy, and acquired protein S deficiency.A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine.Plasmapheresis and steroid treatment of levamisole-induced vasculopathy and associated skin necrosis in crack/cocaine users.Recurrent Levamisole-Induced Agranulocytosis Complicated by Bowel Ischemia in a Cocaine User.
P2860
Q31083824-FE76633E-903C-4D4C-9422-5B4B934C622EQ33400097-C8FB0088-58FD-489E-8FA3-DB82278031AFQ34027242-2037D31A-130B-4915-A8A1-53BD0C77B65EQ34031280-227B9969-5808-4A2B-897A-18E06D651C68Q34253787-8F5E6681-18E3-41A5-B7BB-ABBC0EE87846Q34283471-3E819EC4-F8B6-4B60-B6A8-E69E1F522559Q35045096-6A48B82E-9B7C-4E39-BEDF-D5513C2FC1E5Q35184746-205F6113-2312-44A5-A050-CE60B03767C4Q35568913-AC846CE2-52E0-4A2B-B378-D9605DBCDB26Q35662528-1DD18760-7C9A-4E93-9955-7DA5B95011BCQ35664589-530C68F6-3CD4-4ACE-ACE0-57C8DDAFE160Q37126124-ADE616D0-FC53-480E-9E8F-AFC12E0381A7Q37192436-D92C46C2-D1E6-4986-8F50-9B8F01ACF1F6Q37918694-195C1B78-5805-441E-B11D-28AD10F7EE90Q37957280-1D25D15C-96B9-4F39-BC81-F0ABE53A0085Q37995909-96A0E3CB-DE1A-4078-9C50-4787D4FC43B7Q38123779-2AB4A84E-2855-4459-883E-A684BF1FE64FQ38271339-ACD1D843-23E3-4C0E-B6F5-62E2E3BB36F2Q38631453-D05E8084-379F-4000-A96F-68386953DE19Q39371483-0B265B5C-6A64-4099-AC7A-296077171A97Q41089737-DF0CB610-F226-4EB7-8AD1-574FC6917907Q48186827-46A4D8C9-082E-49B3-A259-9CC920330CF2Q48207976-058EDC6A-8226-459C-8695-F0B8AECC1325Q48246328-D2BA296E-43C9-4216-BB9C-96BE2A3CE73DQ48252158-A5B8DDF5-693D-4EF0-9C36-820444D4D964Q51071350-0C48698F-7AE8-4F35-BF4F-CCDE133491AAQ55266479-40019880-D9F5-4459-ABFF-8C08A4E79727
P2860
Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Clinicopathologic features of ...... of levamisole-tainted cocaine.
@en
Clinicopathologic features of ...... of levamisole-tainted cocaine.
@nl
type
label
Clinicopathologic features of ...... of levamisole-tainted cocaine.
@en
Clinicopathologic features of ...... of levamisole-tainted cocaine.
@nl
prefLabel
Clinicopathologic features of ...... of levamisole-tainted cocaine.
@en
Clinicopathologic features of ...... of levamisole-tainted cocaine.
@nl
P2093
P2860
P356
P1476
Clinicopathologic features of ...... of levamisole-tainted cocaine.
@en
P2093
Afton Martinez
Brian R Curtis
Christina Ewers
David R Czuchlewski
Ian Rabinowitz
Janice G McFarland
Joan Baumbach
Jonaki Manna
Kathryn Foucar
Kurt B Nolte
P2860
P304
P356
10.1309/AJCPOPQNBP5THKP1
P407
P50
P577
2010-03-01T00:00:00Z